Generation Bio Co.

NasdaqGS:GBIO Stok Raporu

Piyasa değeri: US$167.5m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Generation Bio Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Geoff McDonough

İcra Kurulu Başkanı

US$2.3m

Toplam tazminat

CEO maaş yüzdesi27.2%
CEO görev süresi7yrs
CEO sahipliği2.7%
Yönetim ortalama görev süresi3.5yrs
Yönetim Kurulu ortalama görev süresi6.8yrs

Son yönetim güncellemeleri

Recent updates

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

May 01
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Dec 07
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Companies Like Generation Bio (NASDAQ:GBIO) Can Afford To Invest In Growth

Jul 11
Companies Like Generation Bio (NASDAQ:GBIO) Can Afford To Invest In Growth

We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

Mar 11
We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans

Nov 19
Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

Aug 05
We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

Generation Bio GAAP EPS of -$0.66 misses by $0.04

Aug 04

Companies Like Generation Bio (NASDAQ:GBIO) Are In A Position To Invest In Growth

Apr 20
Companies Like Generation Bio (NASDAQ:GBIO) Are In A Position To Invest In Growth

Generation Bio: High-Risk, Medium-To-Low-Reward

Dec 30

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Nov 11
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Jul 28
We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation

Mar 08
Here's Why We're Not Too Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation

Trade Alert: The Independent Director Of Generation Bio Co. (NASDAQ:GBIO), Charles Rowland, Has Just Spent US$500k Buying 25% More Shares

Jan 14
Trade Alert: The Independent Director Of Generation Bio Co. (NASDAQ:GBIO), Charles Rowland, Has Just Spent US$500k Buying 25% More Shares

Generation Bio's insiders on buying spree, stock +4%

Jan 13

Generation Bio prices equity offering at $24.50

Jan 07

Generation Bio files to offer 7.5M shares

Jan 04

Should You Take Comfort From Insider Transactions At Generation Bio Co. (NASDAQ:GBIO)?

Dec 27
Should You Take Comfort From Insider Transactions At Generation Bio Co. (NASDAQ:GBIO)?

Generation Bio EPS misses by $0.01

Nov 10

CEO Tazminat Analizi

Geoff McDonough'un ücretlendirmesi Generation Bio'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$158m

Mar 31 2024n/an/a

-US$169m

Dec 31 2023US$2mUS$630k

-US$127m

Sep 30 2023n/an/a

-US$124m

Jun 30 2023n/an/a

-US$127m

Mar 31 2023n/an/a

-US$134m

Dec 31 2022US$4mUS$606k

-US$137m

Sep 30 2022n/an/a

-US$135m

Jun 30 2022n/an/a

-US$136m

Mar 31 2022n/an/a

-US$129m

Dec 31 2021US$6mUS$583k

-US$119m

Sep 30 2021n/an/a

-US$112m

Jun 30 2021n/an/a

-US$101m

Mar 31 2021n/an/a

-US$88m

Dec 31 2020US$2mUS$516k

-US$81m

Sep 30 2020n/an/a

-US$72m

Jun 30 2020n/an/a

-US$68m

Mar 31 2020n/an/a

-US$65m

Dec 31 2019US$593kUS$424k

-US$61m

Tazminat ve Piyasa: Geoff 'nin toplam tazminatı ($USD 2.32M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.46M ).

Tazminat ve Kazançlar: Geoff 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Geoff McDonough (54 yo)

7yrs

Görev süresi

US$2,315,263

Tazminat

Dr. Cameron Geoffrey McDonough, also known as Geoff, M.D. serves as Independent Director of Third Harmonic Bio, Inc. since March 2024. He had been an Independent Director of Surface Oncology, Inc. since Fe...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Cameron McDonough
President7yrsUS$2.32m2.75%
$ 4.6m
Matthew Norkunas
Chief Financial Officer4.3yrsUS$1.14m0.082%
$ 138.0k
Matthew Stanton
Chief Scientific Officer5.4yrsUS$1.15m0.37%
$ 617.8k
Yalonda Howze
Chief Legal Officer & Secretary1.5yrsUS$1.21m0.018%
$ 29.7k
Mark Angelino
Co-Founder8yrsVeri yokVeri yok
Robert Kotin
Co-Founderno dataVeri yokVeri yok
Antoinette Paone
Chief Operating Officer2.7yrsVeri yok0.022%
$ 37.5k
Jasmin Tower
Chief Human Resources Officer1.6yrsVeri yokVeri yok
Phillip Samayoa
Chief Strategy Officer2.1yrsVeri yok0.18%
$ 304.4k

3.5yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim: GBIO 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.5 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Cameron McDonough
President7yrsUS$2.32m2.75%
$ 4.6m
Jason Rhodes
Independent Chairman7yrsUS$181.21k0%
$ 0
Gustav Christensen
Independent Director6.8yrsUS$143.71k0.20%
$ 329.9k
Charles Rowland
Independent Director6.3yrsUS$151.21k0.80%
$ 1.3m
Anthony Quinn
Independent Director6.8yrsUS$143.71k0.24%
$ 404.9k
Andrew Scharenberg
Chairman of Scientific Advisory Boardno dataVeri yokVeri yok
Donald Nicholson
Independent Director6.8yrsUS$143.71k0.32%
$ 536.1k
Kevin Fitzgerald
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Adrian Thrasher
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Ronald H. Cooper
Independent Director3.6yrsUS$144.21k0.014%
$ 23.8k
Catherine Stehman-Breen
Independent Director6.8yrsUS$143.71k0.071%
$ 119.3k
Richard Thompson
Member of Scientific Advisory Board6yrsVeri yokVeri yok

6.8yrs

Ortalama Görev Süresi

61yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: GBIO 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.8 yıldır).